Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide

Silvia Franceschi(Centre international de recherche sur le cancer), Rolando Herrero(Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud), Gary M. Clifford(Centre international de recherche sur le cancer), Peter J.F. Snijders(Vrije Universiteit Amsterdam), Annie Arslan(Centre international de recherche sur le cancer), Phạm Thị Hoàng Anh(Vietnam National Children's Hospital), F. Xavier Bosch(Institut Català d'Oncologia), Catterina Ferreccio(Pontificia Universidad Católica de Chile), Nguyen Trong Hieu(Hung Vuong Hospital), Eduardo Lazcano‐Ponce(Instituto Nacional de Salud Pública), Elena Matos(Universidad de Buenos Aires), Mónica Molano(Instituto Nacional de Cancerología), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Rajamanickam Rajkumar(Christian Medical College), Guglielmo Ronco, Sílvia de Sanjosé(Institut Català d'Oncologia), Hai‐Rim Shin(National Cancer Center), Sukhon Sukvirach(National Cancer Institute of Thailand), Jaiye O. Thomas(University of Ibadan), Chris J.L.M. Meijer(Vrije Universiteit Amsterdam), Núbia Muñóz(Instituto Nacional de Cancerología), and the IARC HPV Prevalence Surveys Study Group(Collaborative Group (United States))
International Journal of Cancer
September 21, 2006
Cited by 416

Abstract

An inverse relationship between age and human papillomavirus (HPV) prevalence has been reported in many developed countries, but information on this relationship is scarce in many other parts of the world. We carried out a cross-sectional study of sexually active women from the general population of 15 areas in 4 continents. Similar standardised protocols for women's enrolment, cervical specimen collection and PCR-based assays for HPV testing were used. HPV prevalence in different age groups was compared by study area. 18,498 women aged 15-74 years were included. Age-standardised HPV prevalence varied more than 10-fold between populations, as did the shape of age-specific curves. HPV prevalence peaked below age 25 or 35, and declined with age in Italy, the Netherlands, Spain, Argentina, Korea and in Lampang, Thailand and Ho Chi Minh, Vietnam. This was not the case in Songkla, Thailand nor Hanoi, Vietnam, where HPV prevalence was low in all age groups. In Chile, Colombia and Mexico, a second peak of HPV prevalence was detected among older women. In the poorest study areas in Asia (Shanxi, China and Dindigul, India), and in Nigeria, HPV prevalence was high across all age groups. The substantial differences observed in age-specific curves of HPV prevalence between populations may have a variety of explanations. These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences.


Related Papers

No related papers found

Powered by citation graph analysis